Legal & General Group’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$52.8M Buy
3,148,741
+158,401
+5% +$2.65M 0.01% 607
2025
Q1
$46M Sell
2,990,340
-259,922
-8% -$4M 0.01% 631
2024
Q4
$71.6M Sell
3,250,262
-142,893
-4% -$3.15M 0.02% 561
2024
Q3
$61.1M Buy
3,393,155
+98,277
+3% +$1.77M 0.02% 598
2024
Q2
$53.5M Sell
3,294,878
-277,651
-8% -$4.51M 0.02% 608
2024
Q1
$50.4M Sell
3,572,529
-92,222
-3% -$1.3M 0.01% 634
2023
Q4
$38.3M Buy
3,664,751
+164,227
+5% +$1.71M 0.01% 676
2023
Q3
$35.7M Buy
3,500,524
+4,133
+0.1% +$42.2K 0.01% 683
2023
Q2
$26.3M Buy
3,496,391
+138,117
+4% +$1.04M 0.01% 767
2023
Q1
$29.7M Sell
3,358,274
-6,325,524
-65% -$56M 0.01% 719
2022
Q4
$88.3M Buy
9,683,798
+1,534,941
+19% +$14M 0.03% 489
2022
Q3
$65.8M Buy
8,148,857
+126,299
+2% +$1.02M 0.03% 565
2022
Q2
$60.3M Sell
8,022,558
-219,828
-3% -$1.65M 0.02% 599
2022
Q1
$77.4M Buy
8,242,386
+316,017
+4% +$2.97M 0.02% 588
2021
Q4
$63.5M Sell
7,926,369
-847,309
-10% -$6.79M 0.02% 639
2021
Q3
$85.5M Buy
8,773,678
+45,016
+0.5% +$438K 0.03% 570
2021
Q2
$86.4M Buy
8,728,662
+3,980,002
+84% +$39.4M 0.03% 572
2021
Q1
$54.8M Buy
4,748,660
+2,456,578
+107% +$28.3M 0.02% 645
2020
Q4
$22.1M Sell
2,292,082
-621
-0% -$5.99K 0.01% 823
2020
Q3
$20.7M Sell
2,292,703
-262,187
-10% -$2.36M 0.01% 780
2020
Q2
$31.5M Buy
2,554,890
+81,673
+3% +$1.01M 0.02% 683
2020
Q1
$22.2M Buy
2,473,217
+53,893
+2% +$484K 0.01% 706
2019
Q4
$23.7M Buy
2,419,324
+144,933
+6% +$1.42M 0.01% 766
2019
Q3
$15.6M Buy
2,274,391
+164,071
+8% +$1.13M 0.01% 844
2019
Q2
$19.5M Buy
2,110,320
+272,515
+15% +$2.52M 0.01% 802
2019
Q1
$28.8M Buy
1,837,805
+1,129,595
+160% +$17.7M 0.02% 663
2018
Q4
$10.9M Buy
708,210
+117,894
+20% +$1.82M 0.01% 811
2018
Q3
$12.7M Sell
590,316
-372
-0.1% -$8.01K 0.01% 813
2018
Q2
$14.4M Sell
590,688
-21,231
-3% -$516K 0.01% 785
2018
Q1
$10.5M Buy
611,919
+77,766
+15% +$1.33M 0.01% 812
2017
Q4
$10.1M Buy
534,153
+16,542
+3% +$313K 0.01% 806
2017
Q3
$9.11M Buy
517,611
+650
+0.1% +$11.4K 0.01% 794
2017
Q2
$17.2M Sell
516,961
-73,141
-12% -$2.43M 0.01% 685
2017
Q1
$18.9M Buy
590,102
+32,515
+6% +$1.04M 0.02% 659
2016
Q4
$20.2M Buy
557,587
+537,276
+2,645% +$19.5M 0.02% 634
2016
Q3
$935K Sell
20,311
-8,555
-30% -$394K ﹤0.01% 1425
2016
Q2
$1.45M Sell
28,866
-2,351
-8% -$118K ﹤0.01% 1065
2016
Q1
$1.67M Sell
31,217
-10,110
-24% -$541K ﹤0.01% 954
2015
Q4
$2.71M Buy
41,327
+243
+0.6% +$15.9K ﹤0.01% 863
2015
Q3
$2.32M Buy
41,084
+10,666
+35% +$602K ﹤0.01% 879
2015
Q2
$1.8M Buy
30,418
+8,600
+39% +$508K ﹤0.01% 986
2015
Q1
$1.36M Sell
21,818
-11,747
-35% -$732K ﹤0.01% 1030
2014
Q4
$1.93M Sell
33,565
-13,479
-29% -$775K ﹤0.01% 896
2014
Q3
$2.53M Sell
47,044
-18,217
-28% -$979K ﹤0.01% 822
2014
Q2
$3.42M Sell
65,261
-3,518
-5% -$184K ﹤0.01% 776
2014
Q1
$3.63M Buy
68,779
+20,600
+43% +$1.09M ﹤0.01% 748
2013
Q4
$1.93M Sell
48,179
-30,432
-39% -$1.22M ﹤0.01% 825
2013
Q3
$2.97M Sell
78,611
-11,534
-13% -$436K ﹤0.01% 756
2013
Q2
$3.53M Buy
+90,145
New +$3.53M ﹤0.01% 714